physiological levels mediates direct cardiovascular actions.
plasminogen activator) or down-regulated by estrogen The mechanisms and signal pathways responsible for the (e.g., cytokines, adhesion molecules, angiotensin convertcardiovascular protection by estrogen have received great ing enzymes, endothelin-1, angiotensin receptor AT ) [1] .
1 attention in recent years and a wealth of literature in this Estrogen also activates expression of the subtypes of ER, area has been recently reviewed [1] [2] [3] .
thereby promoting the responsiveness to estrogen. Cell 21 Nuclear and putative membrane-bound estrogen recepbiology studies indicate that estrogen modulates Ca and 1 tors (ERs) are present in cardiovascular tissues of women K ion channels of vascular smooth muscle cells, endoand men. ER a and b isoforms mainly form homodimers thelial cells and cardiomyocytes thereby reducing vascular (ERa and ERb) that mediate predominant effects of tone and electrophysiological perturbations [7] [8] [9] . estrogen. Nuclear ERa and ERb regulate gene expression Circulating neutrophils are involved in a number of in two modes. The authentic signalling mode involves cardiovascular events including atherosclerosis, atherosbinding of ERs with specific DNA estrogen-response clerotic plaque rupture, vascular injury following endoelements (EREs) which are located within regulatory thelial damage, and myocardial ischemia / reperfusion inregions of targeted genes. The binding of ERs with ERE jury. Endothelial damage or inflammation triggers local recruits some coactivators thereby modulating machinery accumulation of neutrophils. This is then followed by of gene transcription [4] . The second mode of action is neutrophil adhesion, migration into the subendothelial independent of ERE (i.e., occurs in the absence of a direct layer and activation. Localised neutrophils (macrophages binding of ERs to DNA) and requires interactions of ERs and monocytes) take up low-density lipoproteins to form with promoter elements that directly bind to transcription foam cells and release growth factors leading to smooth factors. These sites include AP-1 sites that bind Jun / Fos, muscle cell growth and migration [10] . Further, neutrophils cyclic AMP response element (CREs) that bind c-Jun / play a pivotal role in platelet activation and myocardial ATF-2, and SP-1 sites [4] [5] [6] . Recently, it is believed that injury following ischemia / reperfusion [11, 12] . In the the rapid nongenomic actions of estrogen are mediated by latter, neutrophils accumulate in the microcirculation and interstitial space and, via release of toxic molecules, cause endothelial dysfunction and tissue injury. Estrogen suppresses expression of several adhesion molecules and is perfusion injury [2, 13] although the mechanisms involved muscle cells [19] . potently inhibits platelet aggregation and neutrophil adheexpression was inhibited by R,R-THC in COS7 cells sion to the vessel wall [16, 17] . Considering that this transfected with ERb, but not with ERa, implying a role of upregulation of ERa and nNOS by estrogen was similar in ERb in promoting NOS expression [21] . Modulation of neutrophils harvested from women and men, it appears NO production by estrogen is one of important biochemireasonable to postulate that the induction of nNOS is cal mechanisms upon which gender differences and benefimediated by ERa alone. The effects of E were partially or cial effects of estrogen in cardiovascular disease are based.
2 completely inhibited by ER antagonists tamoxifen and Thus, taking NOS expression as an endpoint, we have seen ICI-182780, respectively. In this regard, it is interesting to the diversity or even opposite actions by ERa and ERb, know that the affinity for AP-1 binding sites is found largely depending on the cell type studied. Inhibitory fourfold higher for ERa than ERb [18] . Thirdly, their data interactions between ERa and ERb have also been reshowed that ER signal pathway involves binding of ERs to ported in various models [22, 23] . Furthermore, roles of the AP-1 and SP-1 sites as specific inhibitors completely subtypes of ERs on vascular pathophysiology may vary abolished this action. This finding is indicative of nuclear depending on the etiology considering selective activation ERs as the responsible ERs.
of ERb expression following vascular injuries [24, 25] and The role of subtypes of nuclear and membrane ERs on attenuated expression of ERa, but not ERb, by estrogen the cardiovascular system is a key but largely unknown deficiency [26] . In cardiac fibroblasts, hypoxia upregulates issue. A major limitation for research on the ER subtypes expression of ERb and ERE [27] . is the lack of specific ER antagonists. The current research Several issues in the paper by Molero et al. [14] warrant tools involve the use of ER subtype null mouse strains and further comment. A critical matter is to determine the gene transfection. Whereas Molero et al. claimed that in functional implication of the difference in ER expression the human neutrophils, ERa mediated the activation of in neutrophils. In particular, we need to know whether nNOS [14] , this subtype-dependency is likely to vary in neutrophils from women and men behaviour differently different cardiovascular cells. Several recent studies prounder the setting of healthy, aging and cardiovascular vide evidence for this argument [19] [20] [21] . Zhu et al. disease. Another issue is on the mechanism responsible for recently reported that ERb null mice exhibited profound the increased NO production by estrogen. Stefano and functional and biochemical abnormalities, including encoworkers have reported an enhanced NO production in hanced vasoconstriction, development of hypertension with human neutrophils upon E stimulation [15, 28] . This was mediated by membrane ERs as E conjugated to indicated by a cDNA transfection study [33] , membrane 2 bovine serum albumin (which is membrane impermeable) ERs (ERa subtype) are rich in plasmalemmal caveolae was also able to elicit NO production [15] . Their data where they are coupled with signal transduction molecules, 21 imply that a rise in intracellular Ca is necessary for this including NOS, to form an efficient signalling module action. Interestingly, this group has reported a similar [29, 30] . Whether this mechanism is responsible for the action by E in vascular endothelia [7] . In the study by membrane ER-mediated rapid nongenomic actions in 2 Molero et al., the involvement of nuclear ERa in the neutrophils is worth further investigation. Note that the enhanced nNOS expression is supported by the effectiveslow and genomic actions and rapid membrane actions can ness of specific inhibitors for AP-1 (curcumin) and SP-1 synergize [34, 35] , probably via phosphorylation of nuclear (mithramycin A) [14] . Thus, it is apparent that in neutroERs by protein kinases [34] . phils, E -stimulated NO production has rapid and slow Thus, the study by Molero and colleagues should attract 2 phases mediated by distinct ERs and signal mechanisms. A more interest to this area but, as any good article, has further point is on the finding by Molero et al. that raised key questions. Their previous and present works inhibition of either SP-1 or AP-1 completely prevented the indicate human neutrophil as a useful model for further up-regulation of ER and nNOS [14] . SP-1 and AP-1 are studies on ERs signal transduction [14, 16] , in particular the well documented transcriptional factors [4,6,22]. There has gender-related difference in ER autoregulation. The nature been no evidence to date to indicate interaction or synergy of cell-dependent differences in ER-mediated bioactivity in by these two DNA binding sites [14] . Actually Saville et cardiovascular tissues and neutrophils and its al. have shown that only ERa is able to activate SP-1 in pathophysiological or therapeutical relevance remain to be several cell lines [6] . Addressing this question further determined. Similar studies need to be undertaken on other using neutrophils requires techniques such as transfection cardiovascular cells such as vascular endothelium, vascular of genes with recessive or dominant mutations. Another smooth muscle cells and cardiomyocytes. Further research interesting finding that was only briefly commented on by requires the use of models such as gene-targeted animals Molero et al. is that at equal molar concentration, ICIand gene transfected cells. Studies need to include aged or 182780 was much more potent than tamoxifen in the diseased subjects and the effect of estrogen replacement inhibition of E -induced expression of ERa and nNOS therapy. Finally, we should also consider the necessity of 2 [14] . In contrast, Stefano et al. reported that ICI 182780 examining, in a similar way, the potential action of the failed to block E -stimulated NO production (rapid phase) male steroid, testosterone.
2 in neutrophils but tamoxifen was effective [15] . In vascular endothelial cells, however, several groups have found that, ICI-182780, but not tamoxifen, is able to block E 2 R eferences activated rapid NO production and eNOS expression [29] [30] [31] and there is indeed evidence that ICI-182780 can also mechanism [31] . The difference between the two ER phils from postmenopausal women aged 45-65 years [16] .
[6] Saville B, Wormke M, Wang F et al. Ligand-, cell-, and estrogen
However, age-matched men were not studied. A much less understood area is the mechanism by which classic ERs, like the study by Molero et al. [14] , have been 
